
Is the Fed planning to stick it to savers some more?

The business models of the pharmaceutical industry are undergoing significant shifts that tech investors should monitor closely.

Plotting the price ratio of the two "yellow metals" reveals a surprising better buy in today's markets.

An under-the-radar metals play is offering investors strong near-term potential.